Literature DB >> 22263079

Stereotactic ablative radiotherapy for stage I NSCLC: Successes and existing challenges.

Joe Y Chang1.   

Abstract

Year:  2011        PMID： 22263079      PMCID： PMC3256526          DOI： 10.3978/j.issn.2072-1439.2011.06.02

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  11 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.

Authors:  Tingyi Xia; Hongqi Li; Qingxuan Sun; Yingjie Wang; Naibin Fan; Yong Yu; Ping Li; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-09       Impact factor: 7.038

3.  Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies.

Authors:  Suresh Senan; David A Palma; Frank J Lagerwaard
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

4.  Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation.

Authors:  Patrick Kelly; Peter A Balter; Neal Rebueno; Hadley J Sharp; Zhongxing Liao; Ritsuko Komaki; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-08       Impact factor: 7.038

5.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Authors:  Robert Timmerman; Ronald McGarry; Constantin Yiannoutsos; Lech Papiez; Kathy Tudor; Jill DeLuca; Marvene Ewing; Ramzi Abdulrahman; Colleen DesRosiers; Mark Williams; James Fletcher
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

6.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

Authors:  Yasushi Nagata; Kenji Takayama; Yukinori Matsuo; Yoshiki Norihisa; Takashi Mizowaki; Takashi Sakamoto; Masato Sakamoto; Michihide Mitsumori; Keiko Shibuya; Norio Araki; Shinsuke Yano; Masahiro Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

7.  Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.

Authors:  Hui Liu; Xu Zhang; Yevgeniy Y Vinogradskiy; Stephen G Swisher; Ritsuko Komaki; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-27       Impact factor: 7.038

8.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.

Authors:  Frank J Lagerwaard; Cornelis J A Haasbeek; Egbert F Smit; Ben J Slotman; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

9.  Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study.

Authors:  Hiroshi Onishi; Tsutomu Araki; Hiroki Shirato; Yasushi Nagata; Masahiro Hiraoka; Kotaro Gomi; Takashi Yamashita; Yuzuru Niibe; Katsuyuki Karasawa; Kazushige Hayakawa; Yoshihiro Takai; Tomoki Kimura; Yutaka Hirokawa; Atsuya Takeda; Atsushi Ouchi; Masato Hareyama; Masaki Kokubo; Ryusuke Hara; Jun Itami; Kazunari Yamada
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

Review 10.  Image-guided radiation therapy for non-small cell lung cancer.

Authors:  Joe Y Chang; Lei Dong; Helen Liu; George Starkschall; Peter Balter; Radhe Mohan; Zhongxing Liao; James D Cox; Ritsuko Komaki
Journal:  J Thorac Oncol       Date:  2008-02       Impact factor: 15.609
View more
  3 in total

1.  Double CT imaging can measure the respiratory movement of small pulmonary tumors during stereotactic ablative radiotherapy.

Authors:  Ge Shen; Ying-Jie Wang; Hong-Guo Sheng; Xiao-Ping Duan; Jun-Liang Wang; Wei-Jing Zhang; Zhen-Shan Zhou; Guang-Ying Zhu; Ting-Yi Xia
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

2.  The impact of anatomic tumor location on inter-fraction tumor motion during lung stereotactic body radiation therapy (SBRT).

Authors:  Katelyn M Atkins; Yiyi Chen; David A Elliott; Tulsee S Doshi; Sanja Ognjenovic; Arjun S Vachhani; Monica Kishore; Steven L Primack; Martin Fuss; Mark E Deffebach; Charlotte Dai Kubicky; James A Tanyi
Journal:  J Radiosurg SBRT       Date:  2015

3.  Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team.

Authors:  Shervin M Shirvani; Joe Y Chang
Journal:  Cancers (Basel)       Date:  2011-09-01       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.